Arsenal Bio
Arsenal Bio is a programmable cell therapy company engineering T cells to treat solid tumors and other cancers.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $220M
About
Arsenal Bio is a programmable cell therapy company engineering T cells to treat solid tumors and other cancers.
OncologyCell TherapyCRISPR
Funding History
1Total raised:$220M
Series B$220M